Produced using Dyadic’s proprietary high-yield fungal microbial expression platforms and Fermbox Bio’s scale-up and biomanufacturing capabilities, Recombinant DNase I (RNase-free) is currently ...

The Central Drugs Standard Control Organization (CDSCO) has announced that all applications related to Post Approval Changes ...

Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...

Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Ngenla Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Ngenla ...

Gene therapy offers significant opportunities globally due to its potential in treating genetic disorders. Current strategies involve modified viral vectors for gene delivery, with applications in ...

Researchers developed an mRNA delivery system designed to improve embryo implantation. This approach could enhance ART outcomes and address uterine-factor infertility, with pre-clinical studies ...

Cas9, Transcription Activator-Like Effector Nucleases (TALENs), and Zinc-Finger nucleases (ZFNs) have demonstrated great utility, primarily for genetic knock-out applications, none have been adopted ...

The Hong Kong Productivity Council launched a dedicated facility for research and development in healthcare and lifestyle technology applications.

David Baltimore (March 7, 1938 – September 6, 2025) was an American biologist, university administrator, and 1975 ...

In the ever changing biotherapeutics landscape, antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) success ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...